SHANGHAI, Jan. 7, 2012 /PRNewswire/ -- The Twelfth Five-Year plan has directed that through the year of 2015, the development of bio-ceramics, medical metals and other such biomedical materials will increase significantly in China. As to Biomedical Materials projects, it is clearly pointed out that the state will vigorously develop medical polymer materials, bio-ceramics, medical metals and alloys, along with related products to meet the demand for artificial organs, vascular stents and implants.
To promote the field of materials technologies, life sciences and clinical trials, and reduce R&D risks as well as production costs, BioMed Innovation Summit 2013 will launch on 14-15 March 2013 in Shanghai, China. This conference aims to establish a business platform for medical device companies, materials companies and agencies. The first day will focus on the development of biomedical materials used in medical devices, as well as Biological Evaluation, fatigue analysis and testing technology; the second day will introduce clinical application of biomaterials and advanced biomaterials. All participants will have the opportunity to expand business relations and get a transparent interpretation of future market trends.
To learn more, please login to: www.biomed-innovation.com